 ?您的位置：對(duì)照品 > 對(duì)照品 > 雜質(zhì)對(duì)照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：O870058 |
| 產(chǎn)品名稱：6-Oxo-7-epi Docetaxel (Technical Grade) |
| 產(chǎn)品CAS： |
| 規(guī)格含量：1mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
O870058 |
| 名稱: |
6-Oxo-7-epi Docetaxel (Technical Grade) |
| 分子式: |
C??H??NO?? |
| 外觀: |
白色固體 |
| 熔點(diǎn): |
>180°C (dec.) |
| 分子量: |
821.86 |
| 儲(chǔ)存: |
Amber Vial, -20°C Freezer, Under inert atmosphere |
| 溶解度: |
Chloroform (Slightly), DMSO (Slightly) |
| 類別: |
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Docetaxel impurity. Taxol derivatives are useful for the same cancers for which Taxol (Paclitaxel-P132500) has been shown active, including human ovarian cancer, breast cancer, and malignant melanoma as well as lung cancer, gastric cancer, colon cancer, head and neck cancer, and leukemia. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
